Neurofibromatosis type 1 is a disorder of dysplasia: The importance of distinguishing features, consequences, and complications

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 1, 2010, Pages 9-14

  Riccardi, Vincent Michael ^a  

^a Neurofibromatosis Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPUTATION; ASTROCYTOMA; BLINDNESS; BONE DYSPLASIA; BRAIN AQUEDUCT STENOSIS; CAFE AU LAIT SPOT; CARCINOID; CENTRAL NERVOUS SYSTEM DISEASE; COLON DISEASE; COLON HYPERGANGLIONOSIS; CONGENITAL GLAUCOMA; CONGENITAL HEART MALFORMATION; CORNEA DISEASE; DEATH; DENTAL CARIES; DYSPNEA; GASTROINTESTINAL STROMAL TUMOR; GLIOMA; HUMAN; HYPERPIGMENTATION; HYPERTENSION; IRIS DISEASE; JUVENILE XANTHOGRANULOMA; LUNG FIBROSIS; MACROCEPHALY; NEUROFIBROMA; NEUROFIBROMATOSIS; NEUROFIBROSARCOMA; NEUROLOGICAL COMPLICATION; PAIN; PARALYSIS; PATHOGENESIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; SHORT STATURE; SKIN HEMANGIOMA; VASCULAR DISEASE; VISUAL IMPAIRMENT; WEAKNESS;

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE SILENCING; GENES, NEUROFIBROMATOSIS 1; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, KNOCKOUT; NEURAL CREST; NEUROFIBROMATOSIS 1;

EID: 75749142748     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20616     Document Type: Review

References (49)

1. Atit R, Crowe M, Greenbalgh D, et al. 1999. The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation and collagen deposited by fibroblasts. J Invest Dermatol 112:835-842.
2. Daston MM, Ratner N. 1992. Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev Dyn 195:216-226.
3. Ferner RE, Huson SM, Thomas N, et al. 2007. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81-88.
4. Harkin JC, Reed RJ. 1969. Tumors of the peripheral nervous system. In:Atlas of tumor pathology. Second series. Washington, DC: Armed Forces Institute of Pathology. pp. 67-106.
5. Huson S, Hughes RAC. 1994. The neurofibromatoses. London: Chapman and Hall.
6. Jaakkola S, Peltonen J, Riccardi V, et al. 1989a. Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineurial cells, and fibroblasts in mixed cultures. J Clin Invest 84:253-261.
7. Jaakkola S, Peltonen J, Uitto J, 1989b. Extracellular matrix gene expression by Schwann cells, perineurial cells and fibroblasts cultured from cutaneous neurofibromas. Clin Res 37:635A.
8. Jacks T, Shih TS, Schmitt EM, et al. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genet 7:353-361.
9. Joseph NM, Mosher JT, Buchstaller J, et al. 2008. The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell 13:129-140.
10. Joseph NM, Mukouyama Y, Mosher JT, et al. 2004. Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells. Development 131:5599-5612.
11. Kaufmann D. 2008. Neurofibromatosis. Basel, Switzerland: Karger.
12. Lammert M, Friedman JM, Roth HJ, et al. 2006. Vitamin D deficiency associated with number of neurofibromas in Neurofibromatosis 1. J Med Genet 43:810-813.
13. Masson P., 1970. Human tumors. Detroit: Wayne State University Press.
14. Munchhof AM, Li F, White HA, et al. 2006. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. Hum Mol Genet 15:1858-1869.
15. Riccardi VM. 1979. Cell-cell interaction as an epigenetic determinant in the expression of mutant neural crest cells. Birth Defects Orig Artic Ser 15;89-98.
16. Riccardi VM. 1981a. Cutaneous manifestations of neurofibromatosis cellular interaction, pigmentation, and mast cells. Birth Defects Orig Artic Ser 17:129-145.
17. Riccardi VM. 1981b. Von Recklinghausen neurofibromatosis. N Engl J Med 305:1617-1627.
18. Riccardi VM. 1987. Mast cell stabilization to decrease neurofibroma growth: preliminary experience with ketotifen. Arch Dermatol 123:1011-1016.
19. Riccardi VM. 1988. Editorial: NF is more than neurofibromas. Neurofibromatosis 1:1-2.
20. Riccardi VM. 1990. The potential role of trauma and mast cells in the pathogenesis of neurofibromas. In: Ishibashi Y, Hori Y, editors. Tuberous sclerosis and neurofibromatosis: epidemiology, pathophysiology, biology and management. Amsterdam: Elsevier. pp. 167-190.
21. Riccardi VM. 1992. Neurofibromatosis: phenotype, natural history and pathogenesis. Baltimore: Johns Hopkins University Press.
22. Riccardi VM. 1993. A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching. Arch Dermatol 129:577-581.
23. Riccardi VM. 2000a. Histogenesis control genes and neurofibromatosis 1. Eur J Pediatr 159:475-476.
24. Riccardi VM. 2000b. Of mass and men: neurofibromas and histogenesis. Arch Dermatol 136:1257-1258.
25. Riccardi VM. 2000c. The vasculopathy of NF1 and histogenesis control genes. Clin Genet 58:345-347.
26. Riccardi VM. 2007. The genetic predisposition to and histogenesis of neurofibromas and neurofibrosarcoma in neurofibromatosis type 1. Neurosurg Focus 22:E3.
27. Riccardi VM, Eichner JE. 1986. Neurofibromatosis: phenotype, natural history, and pathogenesis. Baltimore: Johns Hopkins University Press.
28. Riccardi VM, Maragos VA. 1980. The pathophysiology of neurofibromatosis. I. Resistance in vitro to 3-nitrotyrosine as an expression of the mutation. In Vitro 16:706-714.
29. Riccardi VM, Maragos VA. 1981. Characteristics of skin and tumor fibroblasts from neurofibromatosis patients. Adv Neurol 29:191-198.
30. Rubenstein AE, Korf BR. 1990. Neurofibromatosis: a handbook for patients, families, and health care professionals. New York: National NF Foundation.
31. Shannon KM, O'Connell P, Martin GA, et al. 1994. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597-601.
32. Sherman LS, Atit R, Rosenbaum T, et al. 2000. Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts. J Biol Chem 275:30740-30745.
33. Sunderland S. 1945. The adipose tissue of peripheral nerves. Brain 68:118-124.
34. Sunderland S, Bradley KC. 1952. The perineurium of peripheral nerves. Anat Rec 113:125-141.
35. Sunderland S, Bradley KC. 1961a. Stress-strain phenomena in denervated peripheral nerve trunks. Brain 84:125-127.
36. Sunderland S, Bradley KC. 1961b. Stress-strain phenomena in human peripheral nerve trunks. Brain 84:102-119.
37. Teixeira F, Martinez-Palomo A, Riccardi VM, Fernandez-Diez J. 1988. Vascular changes in neurofibromas. Neurofibromatosis 1:5-16.
38. Verheijen MHG, Chrast R, Burrola P, Lemke G. 2003. Local regulation of fat metabolism in peripheral nerves. Genes Dev 17:2450-2464.
39. Viskochil D, White R, Cawthon R. 1993. The neurofibromatosis type 1 gene. Annu Rev Neurosci 16:183-205.
40. Vogel KS, Brannan CI, Jenkins NA, et al. 1995. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 82:733-742.
41. Von Recklinghausen F. 1882. Uber die Multiplen Fibrome der Haut und ihre Beziehung zu Multiplen Neuromen. Berlin: August Hirschwald.
42. Walker JA, Tchoudakova AV, McKenney PT, et al. 2006. Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons. Genes Dev 20:3311-3323.
43. Wu J, Crimmins JT, Monk KR, et al. 2006a. Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma. Am J Pathol 168:1686-1696.
44. Wu M, Wallace MR, Muir D. 2006b. Nf1 haploinsufficiency augments angiogenesis. Oncogene 25:2297-2303.
45. Wu X, Estwick SA, Chen S, et al. 2006c. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/ progenitor cells. Hum Mol Genet 15:2837-2845.
46. Yan J, Chen S, Zhang Y, et al. 2008. Rac1 mediates the osteoclast gains-infunction induced by haploinsufficiency of Nf1. Hum Mol Genet 17:936-948.
47. Yang F-C, Ingram DA, Chen S, et al. 2003. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J Clin Invest 112:1851-1861.
48. Yang FC, Ingram DA, Chen S, et al. 2008. Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow. Cell 135:437-448.
49. Zheng H, Chang L, Patel N, et al. 2008. Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. Cancer Cell 13:117-128.